AtriCure (ATRC) Misses Q4 EPS by 14c, Revenues Miss; Offers 1Q & FY21 EPS/Revenue Guidance Below Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| AtriCure, Inc. (NASDAQ: ATRC) | Delayed: 58.97 -0.33 (0.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $59.30 | 52 Week High | $23.24 | |||
| Open | $58.94 | 52 Week Low | $13.44 | |||
| Day High | $59.56 | P/E | N/A | |||
| Day Low | $58.53 | EPS | $-0.45 | |||
| Volume | 497,156 | |||||
